Immunohistochemical profile of endometrioid adenocarcinomas of various degrees of morphological atypism

Topicality. Endometrioid adenocarcinoma of the endometrium is a significant part of malignant neoplasms of the uterine body, which, in turn, are the 2nd most common in menopausal women in 2022, according to the Cancer Registry of Ukraine. The absence of a specific clinical picture, similarity to other variants of adenocarcinoma of the uterine body necessitates the study of histological and immunohistochemical criteria to determine the degree of morphological atypism. Purpose. To improve the differential diagnostic immunohistochemical criteria for the diagnosis of endometrioid adenocarcinoma of the endometrium, using the latest international classification data and taking into account the peculiarities of the diagnostic process in Ukraine. Methods. Retrospective analysis of 61 cases of postoperative material of women diagnosed with "endometrioid adenocarcinoma of the endometrium" for the period from 2021 to 2023 included the assessment of morphological, histological, immunohistochemical features with subsequent statistical processing of the results. Results. The ranking of women with a diagnosis of endometrioid adenocarcinoma of the endometrium by age ranged from 30 to 85 years, the most common diagnosis of "endometrioid adenocarcinoma" is in the menopause and postmenopausal period. Markers p63 (strong connection), p16 (relatively strong connection), p53 (medium strength connection) had a statistically significant relationship for endometrioid adenocarcinoma (p<0.001). There is no relationship between the level of CK20 expression and the degree of morphological atypism. Immunohistochemical profile of endometrioid adenocarcinoma p63 "-" (for grade 1 - "+" in part of cells) / p16 "+" in part of cells (for grade 1 - "-") / p53 "-" / Vimentin "+" / CK7 "+ " / CK20 "-". Conclusion. The necessity of using a panel of cytokeratins 7 and 20, Vimentin, p63, p16, p53 in endometrioid adenocarcinomas of the endometrium to determine the degree of morphological atypism is argued.

Authors

Publication Details

Journal
Morphologia
Published
2024-10-30
DOI
https://doi.org/10.26641/1997-9665.2024.3.110-116
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunohistochemical profile of endometrioid adenocarcinomas of various degrees of morphological atypism

I. S. Shponka, P. O. Hrytsenko, П. В. Савченко
Morphologia
Endometrial and Cervical Cancer Treatments
article

Immunohistochemical profile of endometrioid adenocarcinomas of various degrees of morphological atypism

I. S. Shponka, P. O. Hrytsenko, П. В. Савченко
article en

Abstract

Topicality. Endometrioid adenocarcinoma of the endometrium is a significant part of malignant neoplasms of the uterine body, which, in turn, are the 2nd most common in menopausal women in 2022, according to the Cancer Registry of Ukraine. The absence of a specific clinical picture, similarity to other variants of adenocarcinoma of the uterine body necessitates the study of histological and immunohistochemical criteria to determine the degree of morphological atypism. Purpose. To improve the differential diagnostic immunohistochemical criteria for the diagnosis of endometrioid adenocarcinoma of the endometrium, using the latest international classification data and taking into account the peculiarities of the diagnostic process in Ukraine. Methods. Retrospective analysis of 61 cases of postoperative material of women diagnosed with "endometrioid adenocarcinoma of the endometrium" for the period from 2021 to 2023 included the assessment of morphological, histological, immunohistochemical features with subsequent statistical processing of the results. Results. The ranking of women with a diagnosis of endometrioid adenocarcinoma of the endometrium by age ranged from 30 to 85 years, the most common diagnosis of "endometrioid adenocarcinoma" is in the menopause and postmenopausal period. Markers p63 (strong connection), p16 (relatively strong connection), p53 (medium strength connection) had a statistically significant relationship for endometrioid adenocarcinoma (p<0.001). There is no relationship between the level of CK20 expression and the degree of morphological atypism. Immunohistochemical profile of endometrioid adenocarcinoma p63 "-" (for grade 1 - "+" in part of cells) / p16 "+" in part of cells (for grade 1 - "-") / p53 "-" / Vimentin "+" / CK7 "+ " / CK20 "-". Conclusion. The necessity of using a panel of cytokeratins 7 and 20, Vimentin, p63, p16, p53 in endometrioid adenocarcinomas of the endometrium to determine the degree of morphological atypism is argued.

MorphologiaVol. 18(3)
Openalex Percentile: Top 60%
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immunohistochemical profile of endometrioid adenocarcinomas of various degrees of morphological atypism — I. S. Shponka, P. O. Hrytsenko, et al. · Morphologia (2024) | TGRS Research Map | TGRS